These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2352162)

  • 1. What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations.
    Graham DY; Smith JL; Bouvet AA
    J Pharm Sci; 1990 May; 79(5):420-4. PubMed ID: 2352162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroscopic localization of a microencapsulated KCl preparation in the human stomach.
    Graham DY; Smith JL; Jones RD; Rakhit A; Tipnis V; Hurley ME
    Gastrointest Endosc; 1987 Jun; 33(3):220-3. PubMed ID: 3297914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of five potassium chloride preparations on the upper gastrointestinal mucosa in healthy subjects receiving glycopyrrolate.
    Alsop WR; Moore JG; Rollins DE; Tolman KG
    J Clin Pharmacol; 1984; 24(5-6):235-9. PubMed ID: 6747020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo.
    Sinar DR; Bozymski EM; Blackshear JL
    Clin Ther; 1986; 8(2):157-63. PubMed ID: 3698061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the better formulation of microencapsulated potassium chloride?
    Simoneau G; Bergmann JF; Pamphile R; Caulin C; Segrestaa JM
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):71-5. PubMed ID: 7957455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritative properties of two clinical potassium chloride formulations on duodenal mucosa of the cat and esophageal mucosa of the opossum.
    Alphin RS; O'Dell SW; Sancilio LF; Ward JW
    Dig Dis Sci; 1984 Jun; 29(6):508-12. PubMed ID: 6723482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations.
    Caplain H; Dahan R; Pamphile R; Thebault JJ
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):241-4. PubMed ID: 1814742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vivo disintegration of solid dosage forms of a bile acid sequestrant in dogs using gamma-scintigraphy and correlation to in vitro disintegration.
    Hussain MA; Chang RK; Sandefer E; Page RC; Digenis GA
    Pharm Res; 2003 Mar; 20(3):460-4. PubMed ID: 12669969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz).
    Gao JZh; Hussain MA; Motheram R; Gray DA; Benedek IH; Fiske WD; Doll WJ; Sandefer E; Page RC; Digenis GA
    J Pharm Sci; 2007 Nov; 96(11):2970-7. PubMed ID: 17542016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
    Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
    Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet.
    Betlach CJ; Arnold JD; Frost RW; Leese PT; Gonzalez MA
    Pharm Res; 1987 Oct; 4(5):409-11. PubMed ID: 3508550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of potassium chloride supplements on upper gastrointestinal mucosa.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Clin Pharmacol Ther; 1984 Jun; 35(6):852-5. PubMed ID: 6734038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.
    Sarantopoulos J; Goel S; Chung V; Munster P; Pant S; Patel MR; Infante J; Tawbi H; Becerra C; Bruce J; Kabbinavar F; Lockhart AC; Tan E; Yang S; Carlson G; Scott JW; Sharma S
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):921-927. PubMed ID: 27681579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ulcerogenic effect of potassium chloride by endoscopy and fecal blood loss.
    Lech Y; Hey H; Jørgensen F; Matzen P; Ostergaard O
    J Clin Pharmacol; 1987 Mar; 27(3):206-9. PubMed ID: 3680575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic evaluations of potentially ulcerogenic drugs. A new in vivo porcine test model.
    Hey H; Wamberg T; Rasmussen M; Jørgensen F
    Eur Surg Res; 1987; 19(5):312-7. PubMed ID: 3653159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct visualizing of paracetamol immediate release tablet disintegration in vivo and in vitro.
    Fredholt F; Di Meo C; Sloth S; Müllertz A; Berthelsen R
    Eur J Pharm Biopharm; 2022 Nov; 180():63-70. PubMed ID: 36122785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of potassium from three dosage forms: suspension, capsule, and solution.
    Melikian AP; Cheng LK; Wright GJ; Cohen A; Bruce RE
    J Clin Pharmacol; 1988 Nov; 28(11):1046-50. PubMed ID: 3243918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.
    Bende G; Biswal S; Bhad P; Chen Y; Salunke A; Winter S; Wagner R; Sunkara G
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):76-82. PubMed ID: 27119581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.